ProPhase Labs, Inc.
PRPH
$0.416
$0.00852.09%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 27.16% | -31.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 27.16% | -31.92% | |||
| Cost of Revenue | 12.24% | -27.46% | |||
| Gross Profit | 65.34% | -9.93% | |||
| SG&A Expenses | 6.07% | -5.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.59% | -13.67% | |||
| Operating Income | -1.41% | 5.68% | |||
| Income Before Tax | -7.76% | 4.43% | |||
| Income Tax Expenses | -9.66% | 10.87% | |||
| Earnings from Continuing Operations | -7.05% | 1.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.05% | 1.79% | |||
| EBIT | -1.41% | 5.68% | |||
| EBITDA | 10.68% | 6.08% | |||
| EPS Basic | -5.95% | 6.16% | |||
| Normalized Basic EPS | -6.66% | 8.70% | |||
| EPS Diluted | -6.06% | 5.71% | |||
| Normalized Diluted EPS | -6.66% | 8.70% | |||
| Average Basic Shares Outstanding | 1.01% | 4.67% | |||
| Average Diluted Shares Outstanding | 1.01% | 4.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
